Physician profile
Cassandra Smith
NPI 1811164692
$4,150.26
in general payments reported to CMS, 2019-2025
32 companies · $592 in 2025
The $592 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,914 · 2020: $113 · 2021: $65.67 · 2022: $292 · 2023: $578 · 2024: $596 · 2025: $592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,765.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cdc Medical LLC | $1,560.93 | 2019-2024 | |
| Organogenesis INC. | $557.26 | 2019-2025 | Puraply, Puraply Wound Matrix, Apligraf |
| Smith+Nephew, INC. | $254.83 | 2019-2024 | Collagenase Santyl, Renasys Go V2 Home |
| Averitas Pharma INC. | $225.87 | 2023-2025 | Qutenza |
| Ani Pharmaceuticals, INC. | $189.93 | 2022-2025 | Purified Cortrophin Gel |
| Mimedx Group, INC. | $167.66 | 2025 | |
| Integra Lifesciences Corporation | $144.84 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Depuy Synthes Sales INC. | $124.86 | 2023 | Na, Hammerlock, Va-Lcp |
| Rock Medical Orthopedics, INC. | $119.02 | 2022-2024 | |
| Abbvie INC. | $114.39 | 2023-2025 | |
| Stryker Corporation | $93.24 | 2020-2025 | Ortholoc 3di |
| Bioventus LLC | $74.53 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Pacira Pharmaceuticals Incorporated | $59.60 | 2023-2025 | Exparel, Zilretta |
| Treace Medical Concepts, INC. | $49.52 | 2022-2025 | |
| Paragon 28, INC. | $41.32 | 2022-2025 | R3flex |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $34.26 | 2022 | |
| Kerecis Limited | $33.55 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Kowa Pharmaceuticals America, INC. | $32.51 | 2022-2023 | Seglentis |
| Pfizer INC. | $31.61 | 2019 | |
| Surgenex LLC | $25.25 | 2025 | Surmatrix, Pellograft, Surgraft |
| Solventum Corporation | $23.31 | 2025 | Activ.A.C. Ion Progress |
| Arteriocyte Medical Systems, INC. | $23.00 | 2023 | Magellan |
| Grt US Holding, INC. | $20.96 | 2022 | |
| Medtronic, INC. | $20.59 | 2024 | Venaseal |
| Horizon Therapeutics Plc | $20.44 | 2022 | |
| Biotissue Holdings INC. | $19.79 | 2024 | |
| Melinta Therapeutics, LLC | $17.50 | 2019 | |
| Nevro Corp. | $14.58 | 2023 | Senza |
| Nexus Medical Technologies LLC | $14.44 | 2025 | |
| Boston Scientific Corporation | $14.10 | 2019 | |
| Orthofix Medical, INC. | $13.71 | 2023 | Physio-Stim |
| Merck Sharp & Dohme LLC | $12.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassandra Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.